The Global Anatomic Pathology Market Growth Accelerated By Increased Adoption In Disease Diagnostics
![]() |
Anatomic Pathology Market |
Anatomic pathology involves the
examination of organs, tissues, cells, and bodily fluids to help diagnose and
characterize malignancies and other diseases. It plays a vital role in
understanding disease processes and pathogenesis. The adoption of anatomic
pathology tests and services has increased significantly due to the growing
prevalence of chronic and infectious diseases worldwide. The global Anatomic
Pathology Market is estimated to be valued at US$ 30.16 Bn in 2023 and is
expected to exhibit a CAGR of 15% over the forecast period 2023 to 2030, as
highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends driving the
anatomic pathology market growth is the increasing adoption of
immunohistochemistry (IHC) testing. IHC is an important technique in pathology
used to identify cell types and biomarkers in tissues. It helps in disease
diagnosis and prognosis. The growing application of IHC in disease diagnosis
and drug development is contributing to the increased demand for IHC testing
globally. Advanced automation and digitization are also improving the
efficiency and accuracy of IHC testing, thereby supporting its increased
adoption.
Segment Analysis
The global anatomic pathology
market can be segmented based on type and product type. By type, the market can
be bifurcated into anatomic pathology services and anatomic pathology products.
The anatomic pathology services segment currently dominates the market as it
provides timely diagnosis and treatment options. By product type, the market
can be classified into instruments, consumables, and antibodies. The
consumables segment accounts for the largest share of the market owing to the
recurring requirement for reagents, probes, and others for tissue processing
and slide preparation.
Key Takeaways
The Global
Anatomic Pathology Market Size is expected to witness high growth
during the forecast period of 2023 to 2030.The North American region currently
dominates the global anatomic pathology market owing to advanced healthcare
infrastructure and availability of sophisticated diagnostic techniques in
countries like the United States and Canada.
Regional analysis:
North America is expected to
continue dominating the global anatomic pathology market during the forecast
period. This is attributed to factors such as advanced healthcare
infrastructure, presence of leading market players, and growing adoption of
digital pathology diagnostic solutions in the region. Furthermore, rising
strategic collaborations between industry players and healthcare providers is
positively impacting the market growth.
Key players:
Key players operating in the
anatomic pathology market are Harris Corporation, Airbus Defense and Space, Boeing,
Geooptics Inc., Lockheed Martin Corporation, Millennium Space Systems Inc.,
Northrop Grumman Corporation, OHB AG, OneWeb Ltd, Planet Labs Inc., Sierra
Nevada Corporation, Singapore Technologies Engineering Limited, Space
Exploration Technologies Corp. (Space X), Surrey Satellite Technology Ltd., and
Thales Alenia Space.
Get More Insights Here
Comments
Post a Comment